Evaluation of Minimal Residual Disease As a Surrogate Endpoint for Event Free Survival in Childhood B-Lineage Acute Lymphoblastic Leukemia
Maria Grazia Valsecchi(University of Milano-Bicocca), Stefania Galimberti(University of Milano-Bicocca), Eric Larsen(University of Massachusetts Chan Medical School), Georg Mann(St Anna Children's Hospital), Martin Schrappe(University Hospital Schleswig-Holstein), Stephen P. Hunger(Children's Hospital of Philadelphia), Stefan Sushu(European Organisation for Research and Treatment of Cancer), Andrea Biondi(University of Milano-Bicocca), Giuseppe Basso(University of Padua), Naomi Winick(The University of Texas Southwestern Medical Center), Anja Möricke(University Medical Center), Giovanni Cazzaniga(University of Milano-Bicocca), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Claus R. Bartram(Goethe University Frankfurt), Valentino Conter(Fondazione Matilde Tettamanti Menotti De Marchi), Martin Zimmermann(Stichting Kinderoncologie Nederland), Ausiliatrice Lucenti(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 0
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k